Clinical Trial Update: Radiation Therapy and Rituximab in Treating Patients With Stage I-II Grade 1 or Grade 2 Follicular Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update outlines a study evaluating the combination of radiation therapy and rituximab for early-stage follicular lymphoma (grade 1-2), curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• Rituxan (rituximab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Ann Arbor Stage I Grade 1 Follicular Lymphoma, Ann Arbor Stage I Grade 2 Follicular Lymphoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING